OncoTricks

Sickle cell: acute chest with hemoglobin 4, and the hemoglobin that falls after transfusion, Nov 15, 2026

Acute chest with hemoglobin 4: transfuse now, exchange if the lungs get worse

From rounds

Young adult with HbSS (homozygous sickle cell anemia), new infiltrate, rising oxygen need on a Sunday evening. Hemoglobin 4.1. Apheresis is not available until morning. Give blood now, or wait for the exchange?

Acute chest syndrome: new infiltrate on chest imaging plus fever, chest pain, cough, tachypnea or hypoxemia in sickle cell disease. HbS: sickle hemoglobin, the patient's own. HbA: normal adult hemoglobin, from donor blood. Simple transfusion: add donor red cells. Red cell exchange: apheresis removes the patient's red cells and replaces them with donor cells, so HbS falls without raising viscosity.

Why simple transfusion is enough at hemoglobin 4: the dilution math

HbS (patient)HbA (donor)ceiling, hemoglobin 10

Starting at hemoglobin 4

On arrivalalmost all HbS
Hb 4 · HbS about 95%
Simple transfusion to 10donor cells fill the empty space
Hb 10 · HbS about 38%, nothing removed
Red cell exchangesickle cells out, donor cells in
Hb 10 · HbS under 30%, the exchange target

Starting at hemoglobin 9

On arrivalsame disease, less space
Hb 9 · HbS about 95%
Top up to the ceilingonly 1 g/dL of room
Hb 10 · HbS still about 86%, and the blood is thicker

Low hemoglobin leaves room to dilute HbS by transfusion alone. A higher hemoglobin leaves no room: if that patient needs blood, it is an exchange.

Drawn to scale, 0 to 12 g/dL. Assumes HbSS with about 95% HbS and no ongoing hemolysis; on hydroxyurea HbS starts lower. HbSC or HbS beta-plus thalassemia often start near 10: little room, usually exchange.

Algorithm

Sickle cell + new infiltrateFever, chest pain, cough, tachypnea or low saturation
Everyone, nowOxygen to saturation of 95% or more · cephalosporin plus macrolide · incentive spirometry · opioids · careful fluidsBefore the first unit: hemoglobin electrophoresis (baseline HbS%), extended red cell phenotype, antibody screen · call apheresis early, even if it is not needed yet
Severe or getting worse?Saturation under 90% on oxygen · rising work of breathing · infiltrates spreading · hemoglobin falling despite transfusion · other organs failing
No
Hemoglobin above 9 now?Little room to transfuse: if blood is needed, exchange
Low hemoglobin: simple transfusionAim for 10 and stop there: viscosity
Yes, or worse after transfusion
Red cell exchange, urgentHbS under 30%End hemoglobin about 10 (hematocrit about 30)Automated apheresis preferred
Hemoglobin 4 is not the lungsAcute chest rarely drops hemoglobin this far by itself. Look for the second problem: see the next topic.

What the studies show

StudyWhoFindingNumber to remember
Vichinsky, N Engl J Med 2000671 episodes in 538 patients, 30 centers13% needed mechanical ventilation and 3% died; transfusion improved oxygenation13%ventilated
National Heart, Lung, and Blood Institute (NHLBI) panel, Yawn, JAMA 2014US national guidelineUrgent exchange for rapid progression: saturation under 90% on oxygen, more distress, spreading infiltrates, hemoglobin falling despite transfusionStrongrecommendation, low-quality evidence
American Society of Hematology (ASH) guideline, Chou, Blood Adv 2020Systematic reviewSevere acute chest: suggests exchange over simple transfusion. Moderate: either is acceptableConditionalvery low certainty; 0 randomized trials

Bottom line: the decision is clinical, not driven by trials. Severity and trajectory choose exchange; a low hemoglobin makes simple transfusion work. Vichinsky also shows acute chest alone lowers hemoglobin by less than 1 g/dL on average.

Where people slip

  • Waiting for apheresis while the hemoglobin is 4. Transfuse now; the exchange can follow in the morning.
  • Transfusing past 10. The US panel says do not go above 10 (the UK allows 11). Above that, viscosity rises faster than oxygen delivery. Check hemoglobin after each unit or two.
  • Giving non-phenotyped blood. Matching at least for Rh (C, E) and Kell reduces the alloantibodies that cause the next topic.

Fill the tank to 10, and stop there. Exchange when the lungs get worse, or when there is no room in the tank.

Sources

Retrieved from PubMed and the ASH, NHLBI and British Society for Haematology (BSH) guidelines, read on Nov 16, 2026.

  1. Chou ST, et al. American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support. Blood Adv 2020. doi:10.1182/bloodadvances.2019001143
  2. Yawn BP, et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA 2014. doi:10.1001/jama.2014.10517
  3. Vichinsky EP, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. N Engl J Med 2000. doi:10.1056/NEJM200006223422502
  4. Howard J, et al. Guideline on the management of acute chest syndrome in sickle cell disease. Br J Haematol 2015. doi:10.1111/bjh.13348

Hemoglobin falling in sickle cell: give more blood, or stop giving it?

From rounds

Transfused at another hospital 9 days ago for a pain crisis. Arrives with hemoglobin 4.1; two units bring it only to 5.4. Bilirubin and LDH (lactate dehydrogenase) high, direct antiglobulin test pending. The team asks for a third unit. Will it help, or make it worse?

Aplastic crisis: parvovirus B19 shuts down red cell production for about a week; hemolysis continues at its usual rate, so hemoglobin falls. Sequestration: red cells pooled in the spleen or liver. Delayed hemolytic transfusion reaction (DHTR): destruction of donor cells days after a transfusion, usually from a new alloantibody. Hyperhemolysis: the severe form, where the patient's own cells are destroyed too, so hemoglobin ends below where it was before the transfusion. HbA%: the share of donor hemoglobin on electrophoresis; it shows whether the transfused cells are surviving.

Read the hemoglobin on a timeline

days 5 to 10 before transfusion, Hb 7 1074 071421 days after transfusion transfusion that works aplastic crisis:slides, recovers hyperhemolysis:ends below 7

Schematic. Ended below the dotted line after a transfusion? Not just the donor cells are dying: stop the blood. (Blue had no transfusion.)

Aplastic crisis

Recent transfusion
Usually none
Reticulocytes
Near zero, the key clue
LDH, bilirubin
At the patient's usual level
Confirm
Parvovirus B19 PCR and IgM
Do
Transfuse; droplet isolation

DHTR, hyperhemolysis

Recent transfusion
Yes, usually 5 to 10 days before, up to about 4 weeks
HbA%
Falling: donor cells are disappearing
LDH, bilirubin
Well above baseline, dark urine, new pain
Reticulocytes
Can be low too: does not rule it in or out
Antibodies
Often a new one, but the direct antiglobulin test can be negative
Do
Stop transfusing unless life-threatening

Algorithm

Sickle cell, hemoglobin falling
Transfusion in the last 4 weeks?
No
Reticulocytes near zero?
Yes: aplastic crisisParvovirus PCR · transfuse · droplet isolation · check siblings and contacts with sickle cell
No, spleen or liver growing, platelets fallingSequestration: transfuse small volumes; pooled cells return as it resolves, so do not overshoot
Yes
Send before the next unitHbA% by electrophoresis · LDH, bilirubin, haptoglobin · urine for hemoglobin · direct antiglobulin test · antibody screen and full transfusion history from every hospital
HbA% falling, hemoglobin below the pre-transfusion level?No, HbA% stable: donor cells are surviving; work it up as in the left column
Yes: hyperhemolysis, stop the bloodIVIg (intravenous immunoglobulin) 1 g/kg for 2 days plus high-dose methylprednisoloneErythropoietin, with IV iron if lowStill falling: eculizumab, with meningococcal vaccine and antibiotic prophylaxis (do not wait for the vaccine to give it)Blood only if life-threatening: extended phenotype-matched, under IVIg and steroid

What the studies show

StudyWhoFindingNumber to remember
Habibi, Am J Hematol 201699 DHTR episodes in 69 adults, FranceDark urine 94%, pain crisis 89%, acute chest 50%; median hemoglobin low point 5.5; antibody found in only 62%; more transfusion did not help or made it worse6%died; median onset day 9
ASH guideline, Chou, Blood Adv 2020Systematic reviewFor hyperhemolysis: IVIg plus high-dose steroid first, eculizumab secondVery lowcertainty, conditional recommendation
Dumas, Blood 20163 adolescents and young adults with life-threatening DHTREculizumab stopped hemolysis when steroid and IVIg were not enough3 patientsoff-label; 1 died of infection

Bottom line: the transfusion history and the HbA% make the diagnosis. Reticulocytes do not.

Where people slip

  • Calling it parvovirus because the reticulocytes are low. In hyperhemolysis they can be low too. Ask first: transfusion in the last 4 weeks?
  • Reassured by a negative direct antiglobulin test. It is often negative in hyperhemolysis.
  • Ordering the third unit without the HbA%. If the donor cells are disappearing, more blood feeds the fire.
  • Checking only your own blood bank. Antibodies fade over time; the old one is in another hospital's record.
  • Giving IVIg before drawing the antibody screen. IVIg can interfere with serologic testing; draw first.

Hemoglobin 4 in sickle cell? Think ASH (yes, like the society).

Aplastic: reticulocytes zeroSequestration: spleen or liver growingHemolysis after transfusion: HbA% falling
Sources

Retrieved from PubMed and the ASH and British Society for Haematology (BSH) guidelines, read on Nov 16, 2026.

  1. Chou ST, et al. American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support. Blood Adv 2020. doi:10.1182/bloodadvances.2019001143
  2. Habibi A, et al. Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes. Am J Hematol 2016. doi:10.1002/ajh.24460
  3. Pirenne F, Yazdanbakhsh K. How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions. Blood 2018. doi:10.1182/blood-2018-02-785964
  4. Dumas G, et al. Eculizumab salvage therapy for delayed hemolysis transfusion reaction in sickle cell disease patients. Blood 2016. doi:10.1182/blood-2015-09-669770
  5. Danaee A, et al. Hyperhemolysis in patients with hemoglobinopathies: a single-center experience and review of the literature. Transfus Med Rev 2015. doi:10.1016/j.tmrv.2015.06.001